Trial intelligence / Profile preview

Namenda for memory and attention in mild to moderate TBI

NCT00462228Phase 4Terminated

Sponsor
University of Missouri
Start
Apr 2007
Primary completion
Dec 2010
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of memantine in traumatic brain injury (TBI), sponsored by University of Missouri. Started Apr 2007; status: terminated.

02

Drugs

memantine
03

Conditions

traumatic brain injury (TBI)

Beyond the preview

Go deeper on NCT00462228.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00462228.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call